BKYIIndustrials · Security & Protection Services

BKYI Stock Forecast: BIO-key International, Inc. Price Predictions for 2026-2027

Last close, 7 Aug 2026

$4.03

+1.26% on the day

The 1 Wall Street analysts covering BIO-key International, Inc. hold a median 12-month price target of $20 — +396.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 51 of 100 as at 8 Aug 2026 — in the upper half.

Market cap

$4.4M

Ticker Nerd rank

51 / 100

Median analyst target

$20

Analysts covering

Total return, dividends reinvested

−8.2%

−31.6%

YTD

−25.4%

−47.0%

From 52W high

−60.9%

From 52W low

+16.5%

$10

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

BKYI stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores BIO-key International, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 8 Aug 2026

51 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size

Accruals

Volatility

Revisions

Growth

Quality

Issuance

Value

Momentum

Size (97): Smaller than most of the companies we track.

Momentum (11): The shares have been drifting down relative to others.

The rank is the raw material. Whether the rules would actually own BIO-key International, Inc. — and when they’d sell — is the membership.

Wall Street

BKYI stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on BKYI, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says1 analysts

1 Buy0 Hold0 Sell

Low $20Median $20High $20

The green dot is the last close — the median target sits +396.3% from it.

Recent analyst actionsNewest first

Date	Firm	Action	Rating	Target
26 Mar 2021	Maxim Group	Upgrade	Buy	$6.00
25 Nov 2020	Maxim Group	Downgrade	Hold	—
4 Oct 2019	Maxim Group	Downgrade	Hold	—
16 Aug 2018	Maxim Group	Maintains	Buy	$5.50 → $5.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

BKYI analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year

Analysts raising

Analysts cutting

Fundamentals

BIO-key International, Inc. (BKYI) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: −0.6×
Price / sales: 0.7×
Price / book: 0.9×
EV / EBITDA: −0.8×

Growth & margins

Revenue growth (YoY): 33.5%
Earnings growth (YoY): 33.5%
Gross margin: 82.5%
Operating margin: −7.4%
Net margin: −102.3%

Returns & dividend

Return on equity: −106.7%
Return on assets: −24.8%
Dividend yield: —

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

BKYI vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSecurity & Protection Services

Company	Market cap	TKN rank
BKYIBIO-key International, Inc.	$4.4M	51
IVDAIveda Solutions, Inc.	$3.4M	16
SUGPSU Group Holdings Ltd.	$3.4M	14
VRMEVerifyMe, Inc.	$9.2M	41
GFAIGuardforce AI Co., Ltd.	$11.0M	16
KSCPKnightscope, Inc.	$31.6M	12
SNTSenstar Technologies Corp.	$43.2M	3

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BKYI appears on the weeks it earns a place.

News

Latest BKYI news & analysis

Advanced Authentication Solutions Provider BIO-key Hosts Q2 Investor Call Friday, August 14th at 10am ET

GlobeNewsWire · 7 Aug 2026neutral

BIO-key International announced it will host its Q2 2026 investor call and webcast on Friday, August 14th at 10 a.m. ET. The company is a global provider of Identity and Access Management and biometric authentication technologies.

Why it matters — Investors and followers of BIO-key can obtain updates on the company's second-quarter performance directly from management during the scheduled call and webcast.

BIO-key and Maktabi Tech Partner to Advance Identity Security Across Saudi Arabia's Education Sector

GlobeNewsWire · 6 Aug 2026positive

BIO-key announced a partnership with Maktabi Tech to advance identity security across Saudi Arabia's education sector. The collaboration combines BIO-key's identity and access management (IAM) platform with Maktabi Tech's education market expertise, applying global best practices and regional knowledge to schools in Saudi Arabia.

Why it matters — For BKYI watchers, this signals the company expanding its identity management platform into Saudi Arabia's education market through a regional partner.

Central Bank of Jordan Selects BIO-key for National Biometric Authentication Initiative

GlobeNewsWire · 28 July 2026positive

The Central Bank of Jordan has selected BIO-key for a national biometric authentication initiative aimed at advancing biometric authentication across Jordan's financial sector.

Why it matters — This selection signals that BIO-key's technology is being trusted for a national-level financial infrastructure project, potentially opening the door to further government and central bank contracts.

FAQ

Frequently asked questions about BKYI stock

What is the BKYI stock price forecast for 2026-2027?

The 1 Wall Street analysts covering BIO-key International, Inc. have a median 12-month price target of $20, with estimates ranging from $20 to $20. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is BKYI stock a buy right now?

Of the 1 analysts covering BIO-key International, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks BIO-key International, Inc. 51 out of 100 across roughly 4,600 US stocks as at 8 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank BKYI?

As at 8 Aug 2026, BIO-key International, Inc. ranks 51 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (97 of 100).

Will BKYI stock go up?

No one can know that. What the data says: the median 12-month target from 1 analysts implies +396.3% from the last close, and Ticker Nerd's factor model ranks BIO-key International, Inc. 51 out of 100 as at 8 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the BKYI stock forecast for 2030?

No analyst covering BIO-key International, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BKYI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $20 to $20 over the next 12 months.

How has BKYI stock performed over the past year?

BIO-key International, Inc. returned -47.0% over the 12 months to 7 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does BIO-key International, Inc. do?

Bio-key International Inc. is a provider of biometric identity and access management (IAM) solutions.

What is the latest news on BKYI?

The most recent item we track (GlobeNewsWire, 7 Aug 2026): "Advanced Authentication Solutions Provider BIO-key Hosts Q2 Investor Call Friday, August 14th at 10am ET". BIO-key International announced it will host its Q2 2026 investor call and webcast on Friday, August 14th at 10 a.m. ET. The company is a global provider of Identity and Access Management and biometric authentication technologies.

Company

About BIO-key International, Inc.

Bio-key International Inc. is a provider of biometric identity and access management (IAM) solutions. It develops and markets fingerprint biometric identification, identity verification technologies, and enterprise-ready software for secure authentication. Key products include PortalGuard IAM and IDaaS platforms, which offer passwordless multi-factor authentication (MFA), single sign-on, self-service password reset, and identity-bound biometrics that enable rapid, accurate user verification from large databases. These solutions support cloud, hybrid, and on-premises deployments with high feature parity, flexible integrations, and options for biometrics like SideSwipe and WEB-key. Bio-key International Inc. serves sectors including financial services, healthcare, education, government, manufacturing, transportation, and commercial enterprises, helping organizations secure workforces, students, and partner networks while addressing phishing risks and remote work challenges. Founded in 1993 and headquartered in the United States, it emphasizes affordable, customizable IAM to streamline access and enhance cybersecurity.

CEO Mr. Michael W. DePasquale · 41 employees · United States · https://www.bio-key.com